About the Authors
Biomedical Parasitology Unit, Pasteur Institute, Paris, France
Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
Sedac Therapeutics, Lille, France
PD, DS, PM, SS, CO, and CR are affiliated with the Pasteur Institute, which holds a patent on merozoite surface protein 3.
PD designed the study. DS, GC, PM, SS, and RA performed the biological experiments. PD, SS, RA, and CR analyzed the data. FS organized the clinical trial. AB and CO produced the vaccine. PD wrote the paper.